Compare SSP & OFIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SSP | OFIX |
|---|---|---|
| Founded | 1878 | 1987 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Broadcasting | Medical/Dental Instruments |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 449.7M | 473.3M |
| IPO Year | 1998 | 1998 |
| Metric | SSP | OFIX |
|---|---|---|
| Price | $3.40 | $10.27 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 2 | 5 |
| Target Price | $6.95 | ★ $17.25 |
| AVG Volume (30 Days) | ★ 690.7K | 482.3K |
| Earning Date | 05-07-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 29.39 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $2,150,585,000.00 | $822,312,000.00 |
| Revenue This Year | $8.34 | $6.13 |
| Revenue Next Year | N/A | $6.22 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 2.85 |
| 52 Week Low | $2.04 | $9.13 |
| 52 Week High | $5.39 | $16.99 |
| Indicator | SSP | OFIX |
|---|---|---|
| Relative Strength Index (RSI) | 40.13 | 42.68 |
| Support Level | $3.25 | $9.13 |
| Resistance Level | $3.95 | $12.72 |
| Average True Range (ATR) | 0.21 | 0.62 |
| MACD | 0.02 | -0.03 |
| Stochastic Oscillator | 41.84 | 33.49 |
The E W Scripps Co is a media enterprise with interests in local and national media brands. It owns and operates a collection of daily and community newspapers in medium-sized cities in the southern and western portions of the United States. The company's operating segment includes Local Media, Scripps Networks, and Other. It generates maximum revenue from the Local Media segment. The Local Media segment includes local broadcast stations and their related digital operations.
Orthofix Medical Inc. is a medical device company delivering orthopedic and spine solutions to healthcare providers. The company has two reportable segments: Global Spine and Global Limb Reconstruction. The Global Spine segment offers bone growth therapies, spinal implants, biologics, and enabling technologies used in spinal procedures. The Global Limb Reconstruction segment provides products and solutions for limb deformity correction, limb lengthening, fracture management, and limb preservation, supported by digital technologies. It generates the majority of its revenue from the Global Spine segment.